LATe TreatmENT Related Toxicity in Melanoma (LATENT)

This study is called LATENT, which stands for LATe TreatmENT Related Toxicity in Melanoma. In simple terms, it's about understanding the long-term effects of treatments for advanced melanoma. Melanoma is a serious type of skin cancer, and over the past few years, we've seen fantastic progress with new medicines called immunotherapies. These treatments help your body's own immune system fight the cancer, and they have greatly improved how long people live with advanced melanoma.

While these treatments are very effective, they can also cause side effects. We know about the short-term side effects that many patients experience during treatment. However, because more people are now living longer after treatment, doctors are realising that some patients experience side effects that last for years — these are the 'late-term' effects. At the moment, we don't have enough clear information about how often these long-term side effects happen, how serious they are, or how they affect people's daily lives.

That's why this study is so important. Researchers from leading hospitals like Clatterbridge and Christie's are working together to look back at the medical records of around 400 patients. They will specifically focus on patients who have had advanced melanoma, received immunotherapy, and have responded well to treatment for at least three years. By carefully reviewing these records, the team hopes to build a clearer picture of these late side effects. The information they gather will help doctors provide better, more tailored care and support for patients living well after immunotherapy, making sure any long-term issues are properly managed.